全文获取类型
收费全文 | 4736篇 |
免费 | 260篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 69篇 |
儿科学 | 64篇 |
妇产科学 | 90篇 |
基础医学 | 572篇 |
口腔科学 | 110篇 |
临床医学 | 416篇 |
内科学 | 1640篇 |
皮肤病学 | 58篇 |
神经病学 | 299篇 |
特种医学 | 142篇 |
外科学 | 624篇 |
综合类 | 9篇 |
预防医学 | 185篇 |
眼科学 | 12篇 |
药学 | 256篇 |
中国医学 | 9篇 |
肿瘤学 | 476篇 |
出版年
2023年 | 23篇 |
2022年 | 50篇 |
2021年 | 88篇 |
2020年 | 66篇 |
2019年 | 81篇 |
2018年 | 87篇 |
2017年 | 92篇 |
2016年 | 107篇 |
2015年 | 124篇 |
2014年 | 142篇 |
2013年 | 222篇 |
2012年 | 332篇 |
2011年 | 374篇 |
2010年 | 182篇 |
2009年 | 166篇 |
2008年 | 311篇 |
2007年 | 297篇 |
2006年 | 326篇 |
2005年 | 274篇 |
2004年 | 261篇 |
2003年 | 231篇 |
2002年 | 213篇 |
2001年 | 90篇 |
2000年 | 79篇 |
1999年 | 72篇 |
1998年 | 43篇 |
1997年 | 33篇 |
1996年 | 35篇 |
1995年 | 37篇 |
1994年 | 28篇 |
1993年 | 20篇 |
1992年 | 50篇 |
1991年 | 50篇 |
1990年 | 36篇 |
1989年 | 39篇 |
1988年 | 32篇 |
1987年 | 36篇 |
1986年 | 32篇 |
1985年 | 37篇 |
1984年 | 25篇 |
1983年 | 22篇 |
1982年 | 12篇 |
1981年 | 12篇 |
1979年 | 18篇 |
1977年 | 14篇 |
1976年 | 12篇 |
1974年 | 13篇 |
1973年 | 14篇 |
1971年 | 13篇 |
1969年 | 11篇 |
排序方式: 共有5031条查询结果,搜索用时 15 毫秒
51.
Oxygen consumption (VO2) measured by indirect calorimetry (Nellcor-Puritan-Bennett 7250; Carlsbad, CA, USA) has been compared with VO2 calculated by the Fick method in 22 volume-controlled ventilated general surgical patients in the early post-operative period. For 198 pairs of measurements, VO2 Fick and VO2 indirect calorimetry correlated significantly (y = 1.00x - 35.8, P = 0.0001, r = 0.77). VO2 indirect calorimetry was 212 +/- 32 mL min-1 and VO2 Fick was 177 +/- 41 mL min-1 (P = 0.0001). The bias was 35 +/- 26 mL min-1. This difference represents 16 +/- 13% of the total body VO2. VO2 calculated by the Fick method did not accurately predict VO2 measured by indirect calorimetry, and the two methods were not interchangeable. VO2 calculated by the Fick method underestimated VO2 as measured by indirect calorimetry by a systematic quantity that could be attributed, in part, to VO2 of the lung. Indirect calorimetry should be the preferred method for measuring total body VO2 in mechanically ventilated surgical patients. 相似文献
52.
Santini C 《Annales pharmaceutiques fran?aises》1999,57(1):10-5; discussion 27-8
Under this title will be recalled the responsibilities exerted by the Pharmaceutical Industry in two different fields: in the field of drug production, which has to meet the most rigorous constraints in matter of quality (Good Manufacturing Practices, quality assurance...) under supervision of the pharmaceutical structure; in the field of drug use: after the initial evaluation of the benefit/risk ratio, on which in based the drug registration, it is the responsibility of the Industry to contribute constantly to the good use of medicines and to its optimization (information of health professionals, patient information, pharmacovigilance, and if necessary sanitary safety measures...). 相似文献
53.
54.
Luciano De Carlis Ernesto Del Favero Gianfranco Rondinara Luca S. Belli Cosimo V. Sansalone Bruno Zani Alberto Cazzulani Giorgio Brambilla Antonio Rampoldi Lino Belli 《Transplant international》1992,5(1):9-14
Spontaneous portosystemic shunts are commonly found in cirrhotic patients. Not yet established is their role after orthotopic liver transplantation (OLTx), especially when an increase in portal pressure develops, as during early acute rejection. In this study, 34 cirrhotic patients in a series of 70 OLTx are considered. Each patient had preoperative angiographic assessment, and, in 21 (62%), large spontaneous portosystemic shunts were evident. In 12 cases the shunts were not affected by the surgical procedure and were present during the postoperative period; in 9 the hepatectomy itself involved interruption of the shunts. The patient population was divided into two groups: patients with postoperative shunts (n=12) and those without (n=22). The two groups were similar in age, sex, Child's stage, transplantation variables, and number and grade of rejection episodes. However, mean transaminases (AST) values in the first 2 weeks were significantly higher levels in shunt versus nonshunt patients (421±335 vs 183±126; P<0.025), and this was even more evident when rejection occurred (626±375 vs 195±129; P<0.001). Furthermore, during an acute rejection reaction, three cases showed a true steal phenomenon through the large reopened shunts with ischemic damage to the grafts. The data indicate a possible detrimental effect of the spontaneous shunts on graft perfusion and suggest the prophylactic surgical interruption of the residual shunts during the transplantation. 相似文献
55.
Conzo G Caracò C D'Ardis A Fontanella T Amore A Santini L 《Il Giornale di chirurgia》2000,21(1-2):44-48
The authors report a case of follicular thyroid cancer in "hot nodule" with micronodular synchronous lung metastases. The treatment consisted in TT associated with radioiodine therapy at the dose of 170 mCi with remission of cancer after six months of follow-up. Follicular variant is a prognostic unfavorable factor such as synchronous or metachronous pulmonary metastases. In those patients prognostic unfavorable variants are also age over 40 years, a poor radiofixation capacity, and a lesion of diameter up 1 cm. A strictly instrumental follow-up is mandatory to obtain diagnosis in a subclinical stage. In such cases the radiometabolic therapy agree to a remission of cancer with high survival after many years. TT yet represents a "minimal" surgical treatment for an accurate radioisotopic diagnosis. 相似文献
56.
Evaluation of the Maruyama Computer Program Accuracy for Preoperative Estimation of Lymph Node Metastases from Gastric Cancer 总被引:2,自引:0,他引:2
Guadagni S de Manzoni G Catarci M Valenti M Amicucci G De Bernardinis G Cordiano C Carboni M Maruyama K 《World journal of surgery》2000,24(12):1550-1558
Controversy still exists about the optimal lymph node (LN) dissection for potentially curable gastric cancer. For rational
LN dissection it is important to know the incidence of metastasis at each LN station. For this purpose a computer program
was developed using data from 4302 primary gastric cancers treated at the National Cancer Center Hospital in Tokyo between
1969 and 1989. To evaluate the accuracy of the computer program, the differences between the individual reports generated
by the computer and the stored data were investigated in 282 Italian patients submitted to curative gastrectomy and D2 or more extended LN dissections for gastric cancer. Receiver operating characteristic (ROC) analysis was used to assess the
sensitivity and specificity of the program for predicting LN metastases in each of the 16 regional LN stations. The computer
program showed good predictive ability for LN metastases in most of the 16 LN stations, as the areas under the curve ranged
from 0.741 (station 15) to 0.944 (station 8), with a mean of 0.856. A critical cutoff point of 18% of the program's expected
percentage was the value maximizing the validity of the prediction. Using an “absolute” cutoff point of 0%, the overall rate
of false-negative (FN) predictions in 176 N+ patients was 11.9%; of these, 11 (6.2%) were absolute FNs, in which the program
totally failed to estimate LN metastases; the remaining 10 cases (5.7%) were relative FNs because the specific prediction
was positive for a different depth of stomach invasion. The low number of D3/D4 lymphadenectomies in the historical database may affect the low estimate of metastases to N3/N4 nodes generated by the program. Based on these data, the program predicts with good accuracy the extent of LN metastases
from gastric cancer, but it is not recommended for directing the surgeon to perform more extensive lymphadenectomy. 相似文献
57.
58.
We report one case of solitary gastric metastasis from renal cell carcinoma following radical excision of the primary tumour 14 years previously. During evaluation for a severe anaemia with melaena, a patient underwent upper gastrointestinal endoscopy that evidenced the presence of a small polypoid lesion in the body of the stomach. Endoscopic biopsy revealed renal cell carcinoma. There was no evidence of further metastatic disease. A subtotal gastric resection with Roux-en-Y gastrojejunal reconstruction was performed. After 6 months follow-up, the patient was disease-free. This case confirms the potential of renal cell carcinoma for late and solitary metastasis with circumscribed local invasiveness and suggests that endoscopic resection may be feasible. 相似文献
59.
A Olivieri G Santini C Patti T Chisesi C De Souza A Rubagotti S Aversa A Billio A Porcellini M Candela R Centurioni A M Congiu M Brunori S Nati M Spriano R Vimercati G Marino A Contu L Tedeschi I Majolino M Crugnola M R Sertoli 《Annals of oncology》2005,16(12):1941-1948
BACKGROUND: There is not univocal concordance for using high-dose sequential therapy (HDS) as first-line treatment for aggressive non-Hodgkin's lymphoma (NHL). We designed this study to evaluate the usefulness of HDS followed by high-dose therapy (HDT) with autologous stem cell transplantation as front-line treatment in different subsets of aggressive NHL. PATIENTS AND METHODS: Among 223 patients aged 15-60 years with aggressive, advanced stage NHL, 106 patients were randomized to VACOP-B (etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, bleomycin) for 12 weeks (plus HDS/HDT in case of persistent disease) (arm A), and 117 patients to VACOP-B for 8 weeks plus upfront HDS/HDT (arm B). RESULTS: According to the intention-to-treat analysis, the complete response rate was 75% for arm A and 72.6% for arm B. With a median follow-up of 62 months there was no difference in 7-year probability of survival (60% and 57.8%; P = 0.5), disease-free survival (DFS) (62% and 71%; P = 0.2) and progression-free survival (PFS) (44.9% and 40.9%; P = 0.7) between the two arms. Subgroup analyses confirmed that the best results in terms of survival, DFS and PFS were achieved by patients with large B-cell NHL without bone marrow (BM) involvement, independently of the treatment arm. Results were poorer in other categories of patients and poorest in patients with BM involvement. CONCLUSIONS: Aggressive NHL patients do not benefit from upfront HDS/HDT. 相似文献
60.
Gabriele Grassi Rossella Farra Dr Paolo Caliceti Gianfranco Guarnieri Stefano Salmaso Mario Carenza Mario Grassi 《American Journal of Drug Delivery》2005,3(4):239-251
Thermo-sensitive polymers are appealing materials for several therapeutic applications, such as in regenerative medicine and in situ drug release. These macromolecules are characterized by the ability to undergo swelling/deswelling processes during temperature change-induced phase transitions. Swelling and shrinking temperatures depend on the specific physicochemical properties, namely salt concentration or pH, of the thermo-sensitive gels as well as the incubation environment. An understanding of the mechanisms underlying the gel-swelling equilibrium and kinetics is necessary for the selection of an appropriate gel in relation to the specific pharmaceutical application. Thermo-sensitive polymers used in medicine include polyacrylamides, polyvinyls, polyethers, polysaccharides, and polyphosphazenes. A few of them have been successfully used as 3-dimentional supports for cell cultivation, allowing for the production of scaffolds with excellent biologic properties for application in regenerative medicine. Stem cells that can undergo specific differentiation under the appropriate stimulation have also been cultivated. The ability of drug/polymer solutions to turn into gels at physiologic temperature has been exploited for local drug delivery. The prolonged in situ presence and slow drug release enhances the therapeutic performance of antibiotics used in urogenital pathologies, anti-inflammatory agents, and anticancer drugs. The reduced toxicity as well as lower fluctuations in peak-to-trough drug concentrations make these systems superior to traditional gels. Thermo-sensitive hydrogels have also been demonstrated to be interesting formulations for the delivery of biotechnological drugs. Proteins and oligonucleotides can be loaded under mild conditions, stabilized, and released at a controlled rate. Finally, thermo-reversible polymers have been investigated for protein conjugation to enhance the physicochemical, biologic, immunologic, and pharmacokinetic properties of biotechnological products. 相似文献